Cutaneous melanoma causes 55 500 deaths annually. The incidence and mortality rates of
the disease differ widely across the globe depending on access to early detection and …

Melanoma is characterised by its ability to metastasise at early stages of tumour
development. Current clinico‐pathologic staging based on the American Joint Committee on …

Abstract Background Neurofibromatosis type 1 (NF1: Online Mendelian Inheritance in Man
(OMIM)# 162200) is an autosomal dominantly inherited tumour predisposition syndrome …

Mucosal melanoma is a rare and aggressive subtype of melanoma that has a less favorable
prognosis due to the lack of understanding and identification of oncogenic drivers. Recently …

Melanomas originating from mucosal surfaces have low mutation burden, genomic
instability, and poor prognosis. To identify potential driver genes, we sequenced hundreds of …

Recent developments in oncology have led to a better molecular and cellular understanding
of cancer, and the introduction of novel therapies. Conjunctival melanoma (CoM) is a rare …

Malignant melanoma accounts for the highest number of deaths from skin cancer, and the
prognosis of patients with stage IV disease has historically been poor. Novel insights into …

Melanoma remains mostly an untreatable fatal disease despite advances in decoding
cancer genomics and develo** new therapeutic modalities. Progress in patient care …

Sinonasal mucosal melanoma is a rare tumor arising within the nasal cavity, paranasal
sinuses, or nasopharynx (sinonasal tract). This study evaluated 90 cases diagnosed in 29 …

Background Nivolumab has been widely studied in non-acral cutaneous melanoma;
however, limited data are available in other melanoma subtypes. We report outcomes by …